Discovery of curcumin, a component of golden spice, and its miraculous biological activities

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 3, 2012, Pages 283-299

  Gupta, Subash C ^a   Patchva, Sridevi ^a   Koh, Wonil ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clinical trial; Curcumin; Pleiotropic activity; Polyphenol

Indexed keywords

AMFEBUTAMONE; CURCUMIN; FLUOXETINE; GEMCITABINE; VENLAFAXINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE CORONARY SYNDROME; ADENOMA; ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BETA THALASSEMIA; BIOLOGICAL ACTIVITY; BREAST CANCER; CLINICAL TRIAL; COLORECTAL CANCER; CROHN DISEASE; DEPRESSION; DIABETIC NEPHROPATHY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; DRUG TARGETING; DRUG TOLERABILITY; EPILEPSY; HUMAN; LICHEN PLANUS; LIVER TOXICITY; MULTIPLE MYELOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; PAIN; PANCREAS CANCER; PANCREATITIS; PEPTIC ULCER; PROSTATE CANCER; PSEUDOTUMOR; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS; UVEITIS; VITILIGO;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; CURCUMA; CURCUMIN; HUMANS; INFLAMMATION MEDIATORS;

EID: 84863115185     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05648.x     Document Type: Article

References (191)

1. Vogel, Pelletier J. Examen chimique de la racine de Curcuma. J. Pharm. 1815; i: 289-300.
2. Vogel A Jr. J. Pharm. Chem. 1842; 3: 20.
3. Ivanow-Gajewsky 1870; 3: 624.
4. Ivanow-Gajewsky P. Ber. Dtsch. Chem. Ges. 1872; 5: 1103.
5. Daube FW. Ueber Curcumin, den Farbstoff der Curcumawurzel. Ber. Dtsch. Chem. Ges. 1870; 3: 609-13.
6. Milobedzka J, Kostanecki S, Lampe V. Zur Kenntnis des Curcumins. Ber. Dtsch. Chem. Ges. 1910; 43: 2163-70.
7. Lampe V, Milobedzka J. Studien uber Curcumin. Ber. Dtsch. Chem. Ges. 1913; 46: 2235-7.
8. Srinivasan KR. A chromatographic study of the curcuminoids in Curcuma longa, L. J. Pharm. Pharmacol. 1953; 5: 448-57.
9. Schraufstatter E, Bernt H. Antibacterial action of curcumin and related compounds. Nature 1949; 164: 456-7.
10. Patil TN, Srinivasan M. Hypocholesteremic effect of curcumin in induced hypercholesteremic rats. Indian J. Exp. Biol. 1971; 9: 167-9.
11. Srinivasan M. Effect of curcumin on blood sugar as seen in a diabetic subject. Indian J. Med. Sci. 1972; 26: 269-70.
12. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 1973; 25: 447-52.
13. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. 1976; 25: 1811-12.
14. Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985; 29: 197-202.
15. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [published erratum appears in J. Biol. Chem. 1995; 270: 30235]. J. Biol. Chem. 1995; 270: 24995-5000.
16. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007; 4: 807-18.
17. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64: 353-6.
18. Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 2007; 337: 299-306.
19. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005; 104: 1322-31.
20. Suresh D, Srinivasan K. Studies on the in vitro absorption of spice principles: Curcumin, capsaicin and piperine in rat intestines. Food Chem. Toxicol. 2007; 45: 1437-42.
21. Liu A, Lou H, Zhao L, Fan P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J. Pharm. Biomed. Anal. 2006; 40: 720-7.
22. Preetha A, Banerjee R, Huilgol N. Tensiometric profiles and their modulation by cholesterol: Implications in cervical cancer. Cancer Invest. 2007; 25: 172-81.
23. Ohori H, Yamakoshi H, Tomizawa M et al. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol. Cancer Ther. 2006; 5: 2563-71.
24. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010; 29: 405-34.
25. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008; 269: 199-225.
26. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as 'Curecumin': From kitchen to clinic. Biochem. Pharmacol. 2008; 75: 787-809.
27. Lin JK. Molecular targets of curcumin. Adv. Exp. Med. Biol. 2007; 595: 227-43.
28. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. Br. J. Nutr. 2010; 103: 1545-57.
29. Gupta SC, Prasad S, Kim JH et al. Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep. 2011; 28: 1937-55.
30. Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 2007; 595: 127-48.
31. Lev-Ari S, Starr A, Vexler A et al. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res. 2006; 26: 4423-30.
32. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol. 2007; 72: 29-39.
33. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol. Pharmacol. 2006; 69: 195-206.
34. Gupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM, Aggarwal BB. Role of nuclear factor-{kappa}B-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp. Biol. Med. 2011; 236: 658-71.
35. Jagetia GC, Aggarwal BB. 'Spicing up' of the immune system by curcumin. J. Clin. Immunol. 2007; 27: 19-35.
36. Huang TS, Lee SC, Lin JK. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl Acad. Sci. USA 1991; 88: 5292-6.
37. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res. 1999; 39: 41-7.
38. Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol. 2003; 171: 3863-71.
39. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 1982; 12: 508-15.
40. Nurfina AN, Reksohadiprodjo MS, Timmerman H, Jenie UA, Sugiyanto D, van der Goot H. Synthesis of some symmetrical curcumin derivatives and their antiinflammatory activity. Eur. J. Med. Chem. 1997; 32: 321-8.
41. Anand P, Thomas SG, Kunnumakkara AB et al. Biological activities of curcumin and its analogues (congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008; 76: 1590-611.
42. Ligeret H, Barthelemy S, Zini R, Tillement JP, Labidalle S, Morin D. Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore. Free Radic. Biol. Med. 2004; 36: 919-29.
43. Priyadarsini KI, Maity DK, Naik GH et al. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med. 2003; 35: 475-84.
44. Suzuki M, Nakamura T, Iyoki S et al. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol. Pharm. Bull. 2005; 28: 1438-43.
45. Chen WF, Deng SL, Zhou B, Yang L, Liu ZL. Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation. H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups. Free Radic. Biol. Med. 2006; 40: 526-35.
46. Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1994; 1224: 255-63.
47. Jefremov V, Zilmer M, Zilmer K, Bogdanovic N, Karelson E. Antioxidative effects of plant polyphenols. From protection of G protein signaling to prevention of age-related pathologies. Ann. N. Y. Acad. Sci. 2007; 1095: 449-57.
48. Reddy AC, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol. Cell. Biochem. 1992; 111: 117-24.
49. Duvoix A, Blasius R, Delhalle S et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005; 223: 181-90.
50. Goel A, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr. Cancer 2010; 62: 919-30.
51. Patel BB, Sengupta R, Qazi S et al. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int. J. Cancer 2008; 122: 267-73.
52. Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J. Neurochem. 2007; 102: 522-38.
53. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res. 2007; 67: 1988-96.
54. Javvadi P, Segan AT, Tuttle SW, Koumenis C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol. Pharmacol. 2008; 73: 1491-501.
55. Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE. Curcumin: A new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol. Head Neck Surg. 2005; 132: 317-21.
56. Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M, Diederich M. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int. J. Oncol. 2011; 38: 603-11.
57. Prakobwong S, Gupta SC, Kim JH et al. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis 2011; 32: 1372-80.
58. Schaaf C, Shan B, Buchfelder M et al. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr. Relat. Cancer 2009; 16: 1339-50.
59. Chen JW, Tang YL, Liu Het al.[Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells]. Hua Xi Kou Qiang Yi Xue Za Zhi 2011; 29: 83-6.
60. Malik M, Mendoza M, Payson M, Catherino WH. Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil. Steril. 2009; 91: 2177-84.
61. Dovigo LN, Pavarina AC, Ribeiro AP et al. Investigation of the photodynamic effects of curcumin against Candida albicans. Photochem. Photobiol. 2011; 87: 895-903.
62. Neelofar K, Shreaz S, Rimple B, Muralidhar S, Nikhat M, Khan LA. Curcumin as a promising anticandidal of clinical interest. Can. J. Microbiol. 2011; 57: 204-10.
63. Zandi K, Ramedani E, Mohammadi K et al. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line. Nat. Prod. Commun. 2010; 5: 1935-8.
64. Si X, Wang Y, Wong J, Zhang J, McManus BM, Luo H. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J. Virol. 2007; 81: 3142-50.
65. Sharma M, Manoharlal R, Negi AS, Prasad R. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res. 2010; 10: 570-8.
66. Demirovic D, Rattan SI. Curcumin induces stress response and hormetically modulates wound healing ability of human skin fibroblasts undergoing ageing in vitro. Biogerontology 2011; 12: 437-44.
67. Yeon KY, Kim SA, Kim YH et al. Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. J. Dent. Res. 2010; 89: 170-4.
68. Nose M, Koide T, Ogihara Y, Yabu Y, Ohta N. Trypanocidal effects of curcumin in vitro. Biol. Pharm. Bull. 1998; 21: 643-5.
69. Magalhaes LG, Machado CB, Morais ER et al. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res. 2009; 104: 1197-201.
70. Ji HF, Shen L. Interactions of curcumin with the PfATP6 model and the implications for its antimalarial mechanism. Bioorg. Med. Chem. Lett. 2009; 19: 2453-5.
71. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y. Nematocidal activity of turmeric: Synergistic action of curcuminoids. Chem. Pharm. Bull. 1993; 41: 1640-3.
72. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009; 41: 40-59.
73. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol. Sci. 2009; 30: 85-94.
74. -/-) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. J. Appl. Microbiol. 2009; 107: 557-66.
75. Salh B, Assi K, Templeman V et al. Curcumin attenuates DNB-induced murine colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 285: G235-43.
76. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br. J. Pharmacol. 2003; 139: 209-18.
77. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol. Immunotoxicol. 2003; 25: 213-24.
78. Sawatpanich T, Petpiboolthai H, Punyarachun B, Anupunpisit V. Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin. J. Med. Assoc. Thai. 2010; 93(Suppl. 2): S1-8.
79. El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SF, Ahmed AF. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-alpha and free fatty acids. Food Chem. Toxicol. 2011; 49: 1129-40.
80. Seo KI, Choi MS, Jung UJ et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol. Nutr. Food Res. 2008; 52: 995-1004.
81. Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 2009; 139: 919-25.
82. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007; 102: 1095-104.
83. Yang F, Lim GP, Begum AN et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005; 280: 5892-901.
84. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010; 345: 91-104.
85. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 2005; 39: 1119-25.
86. Yu S, Zheng W, Xin N et al. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res. 2010; 13: 55-64.
87. Jagatha B, Mythri RB, Vali S, Bharath MM. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic. Biol. Med. 2008; 44: 907-17.
88. Rajeswari A, Sabesan M. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacol 2008; 16: 96-9.
89. Mehla J, Reeta KH, Gupta P, Gupta YK. Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sci. 2010; 87: 596-603.
90. Gupta YK, Briyal S, Sharma M. Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian J. Physiol. Pharmacol. 2009; 53: 39-46.
91. Kuhad A, Chopra K. Curcumin attenuates diabetic encephalopathy in rats: Behavioral and biochemical evidences. Eur. J. Pharmacol. 2007; 576: 34-42.
92. Verbeek R, van Tol EA, van Noort JM. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem. Pharmacol. 2005; 70: 220-8.
93. King MD, McCracken DJ, Wade FM, Meiler SE, Alleyne CH, Dhandapani KM. Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice. J. Neurosurg. 2011; 115: 116-23.
94. Sahin Kavakli H, Koca C, Alici O. Antioxidant effects of curcumin in spinal cord injury in rats. Ulus Travma Acil Cerrahi Derg. 2011; 17: 14-18.
95. Waknine-Grinberg JH, McQuillan JA, Hunt N, Ginsburg H, Golenser J. Modulation of cerebral malaria by fasudil and other immune-modifying compounds. Exp. Parasitol. 2010; 125: 141-6.
96. Bharal N, Sahaya K, Jain S, Mediratta PK, Sharma KK. Curcumin has anticonvulsant activity on increasing current electroshock seizures in mice. Phytother. Res. 2008; 22: 1660-4.
97. Shukla PK, Khanna VK, Ali MM, Khan MY, Srimal RC. Anti-ischemic effect of curcumin in rat brain. Neurochem. Res. 2008; 33: 1036-43.
98. Rao CV, Simi B, Reddy BS. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 1993; 14: 2219-25.
99. Kim JM, Araki S, Kim DJ et al. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1, 2-dimethylhydrazine initiation. Carcinogenesis 1998; 19: 81-5.
100. Ushida J, Sugie S, Kawabata K et al. Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn. J. Cancer Res. 2000; 91: 893-8.
101. Hecht SS, Kenney PM, Wang M et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett. 1999; 137: 123-30.
102. Okazaki Y, Iqbal M, Okada S. Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim. Biophys. Acta 2005; 1740: 357-66.
103. Ikezaki S, Nishikawa A, Furukawa F et al. Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride in rats. Anticancer Res. 2001; 21: 3407-11.
104. Chuang SE, Cheng AL, Lin JK, Kuo ML. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem. Toxicol. 2000; 38: 991-5.
105. Azuine MA, Bhide SV. Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis. Int. J. Cancer 1992; 51: 412-15.
106. Huang MT, Lou YR, Xie JG et al. Effect of dietary curcumin and dibenzoylmethane on formation of 7, 12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 1998; 19: 1697-700.
107. Sindhwani P, Hampton JA, Baig MM, Keck R, Selman SH. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J. Urol. 2001; 166: 1498-501.
108. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A, Dunn FW. Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett. 1997; 116: 197-203.
109. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 1994; 54: 5841-7.
110. Swamy MV, Citineni B, Patlolla JM, Mohammed A, Zhang Y, Rao CV. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr. Cancer 2008; 60(Suppl. 1): 81-9.
111. Purkayastha S, Berliner A, Fernando SS et al. Curcumin blocks brain tumor formation. Brain Res. 2009; 1266: 130-8.
112. Narayanan NK, Nargi D, Randolph C, Narayanan BA. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer 2009; 125: 1-8.
113. Prakobwong S, Khoontawad J, Yongvanit P et al. Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. Int. J. Cancer 2011; 129: 88-100.
114. Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int. J. Cancer 2004; 111: 381-7.
115. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001; 47: 293-303.
116. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007; 67: 3853-61.
117. Li L, Ahmed B, Mehta K, Kurzrock R. Liposomal curcumin with and without oxaliplatin. Effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol. Cancer Ther. 2007; 6: 1276-82.
118. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S. Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin. Hemorheol. Microcirc. 2005; 33: 127-35.
119. Aggarwal BB, Shishodia S, Takada Y et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 2005; 11: 7490-8.
120. Lin YG, Kunnumakkara AB, Nair A et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin. Cancer Res. 2007; 13: 3423-30.
121. Tian B, Wang Z, Zhao Y et al. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett. 2008; 264: 299-308.
122. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: Involvement of serotonin and dopamine system. Psychopharmacology 2008; 201: 435-42.
123. Xu Y, Ku BS, Yao HY et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol. Biochem. Behav. 2005; 82: 200-6.
124. Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K. Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology 2009; 214: 33-9.
125. Davis JM, Murphy EA, Carmichael MD et al. Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2007; 292: R2168-73.
126. Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 2008; 1210: 84-91.
127. Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur. J. Pharmacol. 2006; 536: 256-61.
128. Devasena T, Rajasekaran KN, Gunasekaran G, Viswanathan P, Menon VP. Anticarcinogenic effect of bis-1, 7-(2-hydroxyphenyl)-hepta-1, 6-diene-3, 5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacol. Res. 2003; 47: 133-40.
129. Dairam A, Limson JL, Watkins GM, Antunes E, Daya S. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J. Agric. Food. Chem. 2007; 55: 1039-44.
130. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J. Nutr. 2001; 131: 2090-5.
131. Pari L, Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Renal Fail. 2007; 29: 881-9.
132. Murugan P, Pari L. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 2006; 79: 1720-8.
133. Kuttan R, Sudheeran PC, Josph CD. Turmeric and curcumin as topical agents in cancer therapy. Tumori 1987; 73: 29-31.
134. Dhillon N, Aggarwal BB, Newman RA et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008; 14: 4491-9.
135. Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr. Cancer 2010; 62: 1137-41.
136. Kanai M, Yoshimura K, Asada Met al.A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 2011; 68: 157-64.
137. He ZY, Shi CB, Wen H, Li FL, Wang BL, Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 2011; 29: 208-13.
138. Alwi I, Santoso T, Suyono S et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med. Indones. 2008; 40: 201-10.
139. Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: A randomized, parallel-group, placebo-controlled, 8-week study. Drugs R. D. 2008; 9: 243-50.
140. Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin. Ophthalmol. 2010; 4: 1201-6.
141. Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J. Med. Res. 2005; 122: 315-18.
142. Everett PC, Meyers JA, Makkinje A, Rabbi M, Lerner A. Preclinical assessment of curcumin as a potential therapy for B-CLL. Am. J. Hematol. 2007; 82: 23-30.
143. Kamat AM, Sethi G, Aggarwal BB. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol. Cancer Ther. 2007; 6: 1022-30.
144. 1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 2005; 70: 700-13.
145. Howells LM, Mitra A, Manson MM. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines. Int. J. Cancer 2007; 121: 175-83.
146. Bachmeier B, Nerlich AG, Iancu CM et al. The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol. Biochem. 2007; 19: 137-52.
147. Liang G, Zhou H, Wang Y et al. Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin. J. Cell Mol. Med. 2009; 13: 3370-9.
148. Chirnomas D, Taniguchi T, de la Vega M et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther. 2006; 5: 952-61.
149. Rafiee P, Nelson VM, Manley S et al. Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): Role of PKC, MAPKs, and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296: G388-98.
150. Chanvorachote P, Pongrakhananon V, Wannachaiyasit S, Luanpitpong S, Rojanasakul Y, Nimmannit U. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation. Cancer Invest. 2009; 27: 624-35.
151. Kolodziejczyk J, Olas B, Saluk-Juszczak J, Wachowicz B. Antioxidative properties of curcumin in the protection of blood platelets against oxidative stress in vitro. Platelets 2011; 22: 270-6.
152. Alaikov T, Konstantinov SM, Tzanova T, Dinev K, Topashka-Ancheva M, Berger MR. Antineoplastic and anticlastogenic properties of curcumin. Ann. NY Acad. Sci. 2007; 1095: 355-70.
153. Wang JB, Qi LL, Zheng SD, Wu TX. Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J. Zhejiang Univ. Sci. B 2009; 10: 93-102.
154. Hartojo W, Silvers AL, Thomas DG et al. Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl. Oncol. 2010; 3: 99-108.
155. Rao J, Xu DR, Zheng FM et al. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. J. Transl. Med. 2011; 9: 71-85.
156. Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer 2011; 11: 144.
157. Walters DK, Muff R, Langsam B, Born W, Fuchs B. Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest. New Drugs 2008; 26: 289-97.
158. Piantino CB, Salvadori FA, Ayres PP et al. An evaluation of the anti-neoplastic activity of curcumin in prostate cancer cell lines. Int. Braz. J. Urol. 2009; 35: 354-60.
159. Chen YR, Tan TH. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 1998; 17: 173-8.
160. Manikandan R, Beulaja M, Thiagarajan R, Arumugam M. Effect of curcumin on the modulation of alphaA- and alphaB-crystallin and heat shock protein 70 in selenium-induced cataractogenesis in Wistar rat pups. Mol. Vis. 2011; 17: 388-94.
161. Gupta SK, Kumar B, Nag TC et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. 2011; 27: 123-30.
162. Kim JS, Choi JS, Chung SK. The effect of curcumin on corneal neovascularization in rabbit eyes. Curr. Eye Res. 2010; 35: 274-80.
163. Liu K, Shen L, Wang J et al. The preventative role of curcumin on the lung inflammatory response induced by cardiopulmonary bypass in rats. J. Surg. Res. 2010.
164. Moghaddam SJ, Barta P, Mirabolfathinejad SG et al. Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 2009; 30: 1949-56.
165. Suzuki M, Betsuyaku T, Ito Y et al. Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009; 296: L614-23.
166. Cerny D, Lekic N, Vanova K et al. Hepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: Relationship to HO-1/CO antioxidant system. Fitoterapia 2011; 82: 786-91.
167. Charoensuk L, Pinlaor P, Prakobwong S et al. Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Int. J. Parasitol. 2011; 41: 615-26.
168. Jia SH, Wei H, Yu JL, Wei XD, Zhang XP, Li JC. [Protective effects of curcumin on neonatal rats with necrotizing enterocolitis]. Zhongguo Dang Dai Er Ke Za Zhi 2010; 12: 132-6 (in Chinese).
169. Tuorkey M, Karolin K. Anti-ulcer activity of curcumin on experimental gastric ulcer in rats and its effect on oxidative stress/antioxidant, IL-6 and enzyme activities. Biomed. Environ. Sci. 2009; 22: 488-95.
170. De R, Kundu P, Swarnakar S et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 2009; 53: 1592-7.
171. Pinlaor S, Prakobwong S, Hiraku Y, Pinlaor P, Laothong U, Yongvanit P. Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment. Eur. J. Pharmacol. 2010; 638: 134-41.
172. Bruck R, Weiss S, Traister A et al. Induced hypothyroidism accelerates the regression of liver fibrosis in rats. J. Gastroenterol. Hepatol. 2007; 22: 2189-94.
173. Egan ME, Pearson M, Weiner SA et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004; 304: 600-2.
174. Leonhard WN, van der Wal A, Novalic Z et al. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: In vivo evidence from a Pkd1-deletion model. Am. J. Physiol. Renal Physiol. 2011; 300: F1193-202.
175. Shoskes DA. Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: A new class of renoprotective agents. Transplantation 1998; 66: 147-52.
176. Nakmareong S, Kukongviriyapan U, Pakdeechote P et al. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with l-NAME-induced hypertension. Naunyn Schmiedebergs Arch. Pharmacol. 2011; 383: 519-29.
177. Yuan HY, Kuang SY, Zheng X et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol. Sin. 2008; 29: 555-63.
178. Yeh CH, Chen TP, Wu YC, Lin YM, Jing Lin P. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J. Surg. Res. 2005; 125: 109-16.
179. Singer AJ, Taira BR, Lin F et al. Curcumin reduces injury progression in a rat comb burn model. J. Burn Care Res. 2011; 32: 135-42.
180. Sidhu GS, Singh AK, Thaloor D et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen. 1998; 6: 167-77.
181. Jagetia GC, Rajanikant GK. Effect of curcumin on radiation-impaired healing of excisional wounds in mice. J. Wound Care 2004; 13: 107-9.
182. Karaman M, Arikan Ayyildiz Z, Firinci F et al. Effects of curcumin on lung histopathology and fungal burden in a mouse model of chronic asthma and oropharyngeal candidiasis. Arch. Med. Res. 2011; 42: 79-87.
183. Zhang Y, Cao H, Hu YY, Wang H, Zhang CJ. Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis. Int. J. Mol. Med. 2011; 27: 87-94.
184. Agarwal R, Goel SK, Behari JR. Detoxification and antioxidant effects of curcumin in rats experimentally exposed to mercury. J. Appl. Toxicol. 2010; 30: 457-68.
185. Papiez MA, Kaja M, Gebarowska A. Age-dependent different action of curcumin in thyroid of rat. Folia Histochem. Cytobiol. 2008; 46: 205-11.
186. Kumar A, Prakash A, Dogra S. Protective effect of curcumin (Curcuma longa) against d-galactose-induced senescence in mice. J. Asian Nat. Prod. Res. 2011; 13: 42-55.
187. Chen HW, Kuo HT, Chai CY, Ou JL, Yang RC. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia. J. Endotoxin Res. 2007; 13: 15-23.
188. Lee KS, Lee BS, Semnani S et al. Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenat. Res. 2010; 13: 561-70.
189. Tang H, Lu D, Pan R, Qin X, Xiong H, Dong J. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120, V3 loop peptide in rats. Life Sci. 2009; 85: 1-10.
190. Matsushita Y, Ueda H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport 2009; 20: 63-8.
191. Siddiqui RA, Hassan S, Harvey KA et al. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice. Br. J. Nutr. 2009; 102: 967-75.